File Download

There are no files associated with this item.

Supplementary

Article: When compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival

TitleWhen compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival
Authors
Kwok, WCHo, JCMLam, CLDLui, MSMIp, MSMTam, CCT
Issue Date2021
Citation
Asia-Pacific Journal of Clinical Oncology, 2021, v. 17 n. 2, p. e35-e39 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/316257

 

DC FieldValueLanguage
dc.contributor.authorKwok, WC-
dc.contributor.authorHo, JCM-
dc.contributor.authorLam, CLD-
dc.contributor.authorLui, MSM-
dc.contributor.authorIp, MSM-
dc.contributor.authorTam, CCT-
dc.date.accessioned2022-09-02T06:08:18Z-
dc.date.available2022-09-02T06:08:18Z-
dc.date.issued2021-
dc.identifier.citationAsia-Pacific Journal of Clinical Oncology, 2021, v. 17 n. 2, p. e35-e39-
dc.identifier.urihttp://hdl.handle.net/10722/316257-
dc.languageeng-
dc.relation.ispartofAsia-Pacific Journal of Clinical Oncology-
dc.titleWhen compared to plasma-based detection, osimertinib-treated non-small cell lung cancer (NSCLC) with tissue rebiopsy-confirmed acquired T790M mutation is associated with better survival-
dc.typeArticle-
dc.identifier.emailKwok, WC: kwokwch@hku.hk-
dc.identifier.emailHo, JCM: jhocm@hku.hk-
dc.identifier.emailLam, CLD: dcllam@hku.hk-
dc.identifier.emailIp, MSM: msmip@hku.hk-
dc.identifier.authorityKwok, WC=rp02966-
dc.identifier.authorityHo, JCM=rp00258-
dc.identifier.authorityLam, CLD=rp01345-
dc.identifier.authorityIp, MSM=rp00347-
dc.identifier.hkuros336361-
dc.identifier.volume17-
dc.identifier.issue2-
dc.identifier.spagee35-
dc.identifier.epagee39-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats